These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10572974)

  • 21. LC-MS (/MS) in clinical toxicology screening methods.
    Viette V; Hochstrasser D; Fathi M
    Chimia (Aarau); 2012; 66(5):339-42. PubMed ID: 22867548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of new solid-phase extraction methods for chromatographic identification of drugs in clinical toxicological analysis.
    Degel F
    Clin Biochem; 1996 Dec; 29(6):529-40. PubMed ID: 8939400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The general toxicology unknown. I. The systematic approach.
    Wu Chen NB; Schaffer MI; Lin RL; Kurland ML; Donoghue ER; Stein RJ
    J Forensic Sci; 1983 Apr; 28(2):391-7. PubMed ID: 6345717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive drug screening in urine using solid-phase extraction and combined TLC and GC/MS identification.
    Lillsunde P; Korte T
    J Anal Toxicol; 1991; 15(2):71-81. PubMed ID: 2051748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromatographic and spectroscopic methods for the identification of alkaloids from herbarium samples of the genus Uncaria.
    Phillipson JD; Hemingway SR
    J Chromatogr; 1975 Feb; 105(1):163-78. PubMed ID: 1141401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analytical toxicology.
    Maurer HH
    EXS; 2010; 100():317-37. PubMed ID: 20358688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing hair for pharmaceuticals.
    Gaillard Y; Pépin G
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 733(1-2):231-46. PubMed ID: 10572983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automated peak tracking for comprehensive impurity profiling in orthogonal liquid chromatographic separation using mass spectrometric detection.
    Xue G; Bendick AD; Chen R; Sekulic SS
    J Chromatogr A; 2004 Oct; 1050(2):159-71. PubMed ID: 15508308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology.
    Maurer HH
    Ther Drug Monit; 2010 Jun; 32(3):324-7. PubMed ID: 20418802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytical development for low molecular weight xenobiotic compounds.
    Maurer HH; Arlt JW; Kraemer T; Schmitt CJ; Weber AA
    Arch Toxicol Suppl; 1997; 19():189-97. PubMed ID: 9079206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative analysis of pharmacokinetic study samples by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS).
    Mück W
    Pharmazie; 1999 Sep; 54(9):639-44. PubMed ID: 10522267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening procedures for simultaneous detection of several drug classes used for high throughput toxicological analyses and doping control. A review.
    Maurer HH
    Comb Chem High Throughput Screen; 2000 Dec; 3(6):467-80. PubMed ID: 11121516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced hyphenated chromatographic-mass spectrometry in mycotoxin determination: current status and prospects.
    Li P; Zhang Z; Hu X; Zhang Q
    Mass Spectrom Rev; 2013; 32(6):420-52. PubMed ID: 23804155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Estimation of impurity profiles of drugs and related materials. 20. Methodological problems in the identification and determination of organic impurities].
    Görög S
    Acta Pharm Hung; 2000; 70(3-6):131-7. PubMed ID: 11379019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How can analytical diagnostics in clinical toxicology be successfully performed today?
    Maurer HH
    Ther Drug Monit; 2012 Oct; 34(5):561-4. PubMed ID: 22972537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening procedure for detection of non-steroidal anti-inflammatory drugs and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas chromatography-mass spectrometry after extractive methylation.
    Maurer HH; Tauvel FX; Kraemer T
    J Anal Toxicol; 2001; 25(4):237-44. PubMed ID: 11386636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined use of liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) and high performance liquid chromatography with photodiode array detector (HPLC-DAD) in systematic toxicological analysis.
    Broecker S; Pragst F; Bakdash A; Herre S; Tsokos M
    Forensic Sci Int; 2011 Oct; 212(1-3):215-26. PubMed ID: 21764531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic forensic toxicological analysis by liquid-chromatography-quadrupole-time-of-flight mass spectrometry in serum and comparison to gas chromatography-mass spectrometry.
    Grapp M; Kaufmann C; Streit F; Binder L
    Forensic Sci Int; 2018 Jun; 287():63-73. PubMed ID: 29649771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.